Plants have been as medicinal mediators for centuries. Recent trends in agro-biotechnology however, improved the therapeutic roles of plants to a significant level and introduced plant-based oral vaccine which can arouse an immune response in consumer. Although conventional vaccines against infectious diseases have been administrated for years the discovery of plant-based oral vaccines can potentially replace them completely in the future. The probable limitations in conventional vaccines are found to be overcome by plant-based oral vaccines. Humans and animals will no longer be dependent upon local or systemic administration of vaccines but they will just receive the vaccines as a routine food. For the purpose, gene of interest is introduced into plant through transformation, and expression of specific antigen is obtained in plant products which are then consumed by humans or animals. Therefore, plants can serve as bioreactors or bio-factories for production of edible vaccines. A detailed overview about edible vaccines, methods for edible vaccine production, candidate bioreactors and future perspectives of edible vaccines has been summarized in current article. The future of vaccination seems to be present within plant-based vaccination system.

No abstract

Every year, the poultry industry experiences significant economic losses due to epidemics of Newcastle disease virus (NdV). developing new vaccines by identifying and using the immunogenic hemagglutinin-neuraminidase (hN) protein can protect the poultry industry. in the present study, the full-length hN protein was expressed in Escherichia coli (E. coli) Bl21 (dE3) cells, purified via affinity chromatography and detected via western blot analysis using his-specific antibodies. the purified hN protein was further evaluated in chickens to study the immune response against NdV. the successful production of hN-specific igY proved the activity of the purified hN protein. igY was present in the serum of immunized chickens. however, the immune response was higher in chickens immunized with purified hN protein along with complete and incomplete adjuvants than in chickens immunized with only the hN protein.

Vitamin E, administered in vivo and in vitro, has been shown to be a potent modulator of retrovirus-induced immune dysfunctions and tumorigenesis. The immunomodulating effects of vitamin E have been observed in two retrovirus systems, avian erythroblastosis virus (AEV)-induced erythroleukemia and reticuloendotheliosis virus (REV)-induced early lymphoid cell lymphoma. Both viruses possess naturally occurring replicationcompetent helper viruses (AEAV and REVA) that induce severe immune dysfunctions characterized by (i) decreased splenic T cell mitogen responses (ii) increased Ts activity, (iii) depletion of macrophages, (iv) decreased macrophage chemotaxis, (v) initially decreased macrophage phagocytosis, and (vi) thymic aplasia.Immunomodulation by vitamin E has been observed in vivo with dl-alpha tocopherol and in vitro with d-alpha-tocopheryl acid succinate. I Vitamin E (i) reduces or eliminates retrovirus-suppressed splenic T lymphocyte mitogen responses, (ii) reduces or eliminates retrovirus-induced Ts activity, (iii) increases IL-2 production, (iv) reduces suppressed macrophage chemotaxis, and (v) down-regulates PGE z production (TABLE I).A hypothetical model for the immunoregulatory actions by vitamin E is presented in FIGURE I. Although the mechanisms of AEV-and REV-induced immune dysfunctions are not well understood, one possibility is that the helper virus coded p2lE envelope protein, which exhibits sequence homology to feline leukemia pl5E-a well characterized immunosuppressive molecule-is causing the observed immune dysfunctions. Helper virus product(s) are postulated to up-regulate macrophage production of prostaglandin E z (PGE z). Elevated levels of PGE z, in turn, (i) down-regulate interleukin-2 (lL-2) production by T helper cells, and (ii) induce PGEz-receptor bearing T cells to differentiate into T cells with suppressor cell activity. Reduced levels of IL-2 and elevated levels of PGE z could account for the decreased responsiveness of T cells to mitogen stimulation and the increase in Ts activity observed in retrovirus-induced pathogenesis.Vitamin E is postulated to modulate retrovirus-induced immune dysfunctions by down-regulating macrophage production of immunosuppressive PGE z molecules and by up-regulating IL-2 production. Reduced levels of PGE z would result in the elimination of PGE z dependent T s cells, and could permit mitogen-induced T cell proliferation. In addition or alternatively, vitamin E may act directly on subpopulations of T lymphocytes causing up-regulation of IL-2 synthesis, or vitamin E may act directly on macrophages causing up-regulation of IL-I and subsequently up-regulation of IL-2. Direct retroviral